ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
January 28, 2011  |  By ENCOD In 2011

RUSSIA DENIES ITS CITIZENS ADEQUATE DRUG TREATMENT

arton2877

Source: Rylkov Foundation

Press conference on 31 January 2011, 11.00 AM

Address: Moscow, Nikitskiy Boulevard, 8 “A” (Marble Hall of the Central House of Journalists) (Subway station “Arbatskaya”)


January 31, 2010 at 11.00 a press conference “Ineffective Drug Policy promotes the spread of tuberculosis in Russia” will be held in the House of Journalists. This press conference is devoted to highlighting obstacles to effective tuberculosis treatment in our country. We will bring to your attention results of studies in seventeen cities in Russia conducted by the Andrey Rylkov Foundation For Health and Social Justice in cooperation with the project “Simona+“.

Tuberculosis is a curable disease, however due to deficiencies in the healthcare system in Russia, the death rate from tuberculosis in 2009 was 16.5 per 100 thousand population. The Russian Federation occupies the 11th place in the world in absolute number of new cases of tuberculosis, and the third place after China and India by the prevalence of tuberculosis.

People with comorbidity of HIV, tuberculosis and drug dependence, represent one of the most vulnerable groups, in terms of prevention of tuberculosis and mortality. This study showed that in 2009 50 to 86% of all patients living with HIV and tuberculosis were drug dependant people. Extremely high mortality associated this treatable disease was observed in this group, and in three cities tuberculosis mortality reached 100% among patients receiving inpatient treatment. Level of premature termination of treatment is very high; termination of tuberculosis treatment leads to the development of drug-resistant tuberculosis. An average of 41%, and in some cities up to 100% of TB patients with comorbidity of HIV and drug dependence failed to complete their tuberculosis treatment.

Such high level of mortality and premature termination of treatment suggests that the system of medical care does not meet the needs of patients. In particular, effective substance abuse treatment for patients undergoing both inpatient and outpatient treatment does not exist. Substitution treatment with methadone and buprenorphine, included in international standards for treatment of tuberculosis and HIV for drug dependant persons, is prohibited in the Russian Federation.

“The fact that Russia does not provide access to substitution therapy drug dependant persons, has tragic consequences – says Ivan Javoronkov – Head of the organization “Chance +” from Ekaterinburg. – Patients can not tolerate long-term treatment in hospitals or in outpatient services, lose contact with medical institutions, drop out of tuberculosis clinics, thereby jeopardizing their own lives and the lives of others”.

The rapid spread of tuberculosis in Russia is connected to the criminalization of drug dependant persons. Today in Russia prisons are the main source of the disease – because of severe overcrowding, lack of basic hygiene and sanitation, poor infection control and the low level of medical care.

“A lack of adequate drug treatment in Russia results in imprisonment of many people, like myself, for nonviolent drug related crimes, while all these people could work, study, raise children. – Says Irina Teplinskaya, a drug user with experience of undergoing HIV and tuberculosis treatment. – Prisons are a source of tuberculosis, especially for people living with HIV whose immune system is weakened: I and hundreds of my friends contracted TB there. “

The study was conducted in January – November 2010 in 17 cities of Russia with support from the Treatment Preparedness Coalition and the International Harm Reduction Development Program of the Open Society Institute. The study aims at formulating recommendations for improving assistance for people with comorbidities of HIV, tuberculosis and drug dependence.

The following experts will participate in the press conference:

• Anya Sarang, President of the Andrey Rylkov Foundation For Health and Social Justice, Moscow

• Evgenia Maron – Project Coordinator, “Simona+”, Foundation “Astra”, St. Petersburg

• Irina Teplinskaya – Staff member, Andrey Rylkov Foundation For Health and Social Justice, Member of the Steering Committee of the Eurasian Harm Reduction Network from Russia, Kaliningrad

• Ivan Javoronkov – Head of a self-organization of people living with HIV, “Chance +”, Ekaterinburg

This press conference is organized with support from the Levi Strauss Foundation.

Contact information:

+7 926 155 87 99 – Tatiana Ivanova, Project Coordinator, Andrey Rylkov Foundation For Health and Social Justice

Previous StoryPRESS STATEMENT OF THE UNITED STATES EMBASSY IN BOLIVIA
Next StoryHanfwandertag

Related Articles

  • THE TOP TEN INTERNATIONAL DRUG POLICY STORIES OF 2011
  • arton3477
    HOW THE PENTAGON WILL PRIVATIZE THE WAR ON DRUGS

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
RUSSIA DENIES ITS CITIZENS ADEQUATE DRUG TREATMENT